Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MILLER RICHARD A MD
Corvus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samlyn Capital, LLC(9.99%),Samlyn, LP(9.99%), etc.
Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Point72 Asset Management, L.P.(9.9%),Point72 Capital Advisors, Inc.(9.9%), etc.
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Thompson Peter A.
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director ORBIMED ADVISORS LLC
Corvus Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(11.1%),OrbiMed Capital GP V LLC(11.1%)
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jones William Benton
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MILLER RICHARD A MD
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arcara Jeffrey
Corvus Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samlyn Capital, LLC(5.1%),Samlyn, LP(5.1%), etc.
Corvus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard A. Miller(7.19%),Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985(3.04%), etc.
Corvus Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Arcara Jeffrey
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MILLER RICHARD A MD
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer LEA LEIV
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jones William Benton
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mitchell Edith P.
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Grais Linda
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CLARK IAN T
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Scott W
Corvus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gould Terry P
No Data